関連する実験動画
Updated: Jun 22, 2025

10:13
Measuring G-protein-coupled Receptor Signaling via Radio-labeled GTP Binding
Published on: June 9, 2017
16.3K
ナロキソンと協働するμ-オピオイド受容体調節器
Evan S O'Brien1, Vipin Ashok Rangari2, Amal El Daibani2
1Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA, USA.
Nature
|July 3, 2024
まとめ
研究者らは,非活性オピオイド受容体 (μOR) を選択的に標的とする新しい化合物を発見した. このネガティブ・アロステリック・モジュレーター (NAM) は,ナロキソンを強化します.
科学分野:
- 薬理学と医薬品化学
- 神経科学
- 構造生物学
背景:
- ミュアオピオイド受容体 (μOR) は 痛みを和らげる 重要な標的ですが そのアゴニストは 依存症や呼吸器系低下などの 危険な副作用を引き起こし オピオイド危機を助長します
- より安全な鎮痛剤と過剰投与対策の開発は極めて重要であり,マイナスのアロステリック調節剤 (NAM) は有望であるが,効果的な化学的支架がない.
研究 の 目的:
- 新しい,形状的に選択的な μOR NAM を特定し,特徴づけること.
- 発見されたNAMの作用機構を調査し,その構造的基礎とナロキソンとの協力効果を調査する.
- オピオイドによる効果と離脱を緩和するNAMの in vivo 効果を評価する.
主な方法:
- 不活性 μORに対する大規模な DNA 暗号化化学物質のスクリーニング,活性受容体状態に対する対スクリーニング.
- 低温電子顕微鏡 (cryo-EM) で,NAM結合の構造的基礎と受容体の形状への影響を決定する.
- ナロキソンと併用したNAMの有効性を評価するために動物モデルでのin vivo行動研究.
主要な成果:
- 選択的に不活性 μOR に濃縮し,ナロキソン結合を強化する NAM の発見.
- Cryo-EMは,NAMが細胞外前庭に結合し,不活性な受容体構成を安定させ,オーステリックリガンドの運動性を変化させることを明らかにした.
- NAMは低用量ナロキソンと連携し,モルヒネとフェンタニル誘発の行動を in vivoで強力に抑制し,離脱症状を最小限に抑えます.
結論:
- 新しい μOR NAMは,非活性受容体構造を安定させる独特の作用メカニズムで特定されました.
- このNAMは,ナロキソンの有効性を強化し,オピオイドアゴニストの効果を in vivoで協力的に抑制することで,治療的可能性を示しています.
- この発見は,アロステリック調節に関する構造的な洞察を提供し,より安全なオピオイド管理と過剰摂取予防のための有望な戦略を提供します.
さらに関連する動画
関連する概念動画
Opioid Receptors: Overview
704
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
704
Opioid Analgesics: Synthetic and Semisynthetic Opioids
271
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
271
Opioid Analgesics: Morphine and Other Natural Cogeners
225
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
225
Analgesia and Pain Management
568
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
568
Drug-Receptor Interaction: Agonist
2.4K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.4K
Drug-Receptor Interaction: Antagonist
2.9K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
2.9K

